Aviva’s National Instruments Corp NATI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-28,482
Closed -$1.23M 1003
2021
Q1
$1.23M Sell
28,482
-7,667
-21% -$337K 0.01% 802
2020
Q4
$1.59M Sell
36,149
-29,307
-45% -$1.09M 0.01% 747
2020
Q3
$2.34M Buy
65,456
+5,339
+9% +$194K 0.01% 661
2020
Q2
$2.33M Sell
60,117
-53,119
-47% -$2.01M 0.01% 651
2020
Q1
$3.75M Buy
113,236
+69,541
+159% +$2.78M 0.03% 516
2019
Q4
$1.85M Buy
+43,695
New +$1.83M 0.01% 810

Other funds holding NATI

Aviva's NATI Position: Q2 2021 in Review

Aviva sold out of National Instruments Corp (NATI) in Q2 2021, closing a stake of 28,482 shares — an estimated $1.23M sold.

Aviva first reported a position in NATI in Q4 2019 and held it in 6 quarters. The position peaked at $3.75M in Q1 2020. 298 funds tracked by Wall St. Rank hold NATI as of Q2 2021.

  • Aviva reported no remaining National Instruments Corp position as of Q2 2021 after selling out during the quarter.
  • Aviva sold 28,482 National Instruments Corp shares in Q2 2021, an estimated $1.23M.
  • Aviva first reported a position in National Instruments Corp in Q4 2019 and held it in 6 quarters.
  • Aviva's National Instruments Corp position peaked at $3.75M in Q1 2020.
  • 298 funds tracked by Wall St. Rank held National Instruments Corp as of Q2 2021.

Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.